CD4 and neoplasm: Disruption of H3K27 methyltransferase EZH2 activity in Tregs, drove the pro-inflammatory functions of TI-Tregs, remodelling the TME and enhancing the recruitment and function of CD8+ and CD4+ effector T cells that eliminate tumours [115].